Human protoporphyria: genetic heterogeneity at the ferrochelatase locus. 1995

L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
Department of Dermatology, New York Medical College, Valhalla, USA.

Inherited deficiency of ferrochelatase results in erythropoietic protoporphyria (EPP). Genetic heterogeneity at the locus for human ferrochelatase was investigated. Analysis of genomic DNA of patients with EPP and of control subjects by restriction endonuclease techniques using ten different enzymes detected polymorphisms only at sites recognized by EcoRI, HincII, PstI and TaqI. None of these polymorphisms alone was specific for expression of the disease since each was observed in control subjects as well. Three of these polymorphisms (at EcoRI, HincII and PstI sites) were always associated, indicating linkage. These and other studies demonstrate that the ferrochelatase gene is markedly heterogeneous. It is not yet clear whether some of the mutations associated with these polymorphisms contribute to expression of EPP.

UI MeSH Term Description Entries
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005294 Ferrochelatase A mitochondrial enzyme found in a wide variety of cells and tissues. It is the final enzyme in the 8-enzyme biosynthetic pathway of HEME. Ferrochelatase catalyzes ferrous insertion into protoporphyrin IX to form protoheme or heme. Deficiency in this enzyme results in ERYTHROPOIETIC PROTOPORPHYRIA. Heme Synthetase,Porphyrin-Metal Chelatase,Protoheme Ferro-Lyase,Zinc Chelatase,Chelatase, Porphyrin-Metal,Chelatase, Zinc,Ferro-Lyase, Protoheme,Porphyrin Metal Chelatase,Protoheme Ferro Lyase,Synthetase, Heme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017121 Porphyria, Hepatoerythropoietic An autosomal recessive cutaneous porphyria that is due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in both the LIVER and the BONE MARROW. Similar to PORPHYRIA CUTANEA TARDA, this disorder is caused by defects in the fifth enzyme in the 8-enzyme biosynthetic pathway of HEME, but is a homozygous enzyme deficiency with less than 10% of the normal enzyme activity. Cutaneous lesions are severe and mutilating. Hepatoerythropoietic Porphyria,Porphyria, Erythrohepatic,Erythrohepatic Porphyria,Erythrohepatic Porphyrias,Hepatoerythropoietic Porphyrias,Porphyrias, Erythrohepatic,Porphyrias, Hepatoerythropoietic
D018740 Genetic Heterogeneity The presence of apparently similar characters for which the genetic evidence indicates that different genes or different genetic mechanisms are involved in different pedigrees. In clinical settings genetic heterogeneity refers to the presence of a variety of genetic defects which cause the same disease, often due to mutations at different loci on the same gene, a finding common to many human diseases including ALZHEIMER DISEASE; CYSTIC FIBROSIS; LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL; and POLYCYSTIC KIDNEY DISEASES. (Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed; Segen, Dictionary of Modern Medicine, 1992) Heterogeneity, Genetic,Genetic Heterogeneities,Heterogeneities, Genetic

Related Publications

L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
January 1994, Biochimica et biophysica acta,
L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
December 1991, Genomics,
L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
April 2007, Molecular genetics and metabolism,
L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
June 1993, Human molecular genetics,
L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
December 1991, Biochemical and biophysical research communications,
L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
September 2002, The British journal of dermatology,
L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
July 1975, The Journal of laboratory and clinical medicine,
L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
January 1977, Ciba Foundation symposium,
L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
November 2006, Molecular genetics and metabolism,
L T Ostasiewicz, and J L Huang, and X Wang, and S Piomelli, and M B Poh-Fitzpatrick
April 1989, The Journal of dermatology,
Copied contents to your clipboard!